Clearmind Medicine Inc
CMND
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.13M
Close$
$1.19
55.5% downside
Current Fair Value
55.5% downsideOvervalued by 55.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.13 Million |
|---|---|
| Enterprise Value | $-8,160,461.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.03 |
| Beta | -1.32 |
| Outstanding Shares | 301,964 |
Return
| Return on Equity | -83.42% |
|---|---|
| Return on Assets | -66.00% |
| Return on Invested Capital | -76.49% |
Valuation & Multiples
| P/E Ratio | -0.27 |
|---|---|
| PEG | -0.16 |
| Price to Sales | - |
| Price to Book Ratio | 0.07 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.92 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.02 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 15, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 3.87%▲ 3.30% |
|---|---|
| Total Invested | $46,214▲ 284.70% |
| Investors Holding | 4▲ 2.00% |
ESG Score
No data